Heart failure therapy: from past to present
Dr Fisher is a general cardiologist with experience in echocardiography and angiography. She has a special interest in heart failure, disease prevention and teaching and is passionate about developing equitable care for all heart failure patients. As clinical lead for Northland DHB cardiology, and the current chair of the Cardiac Society Heart Failure working group, she has had input into local heart failure care pathways.
What you can expect
Presented by cardiologist Dr Raewyn Fisher, this recorded webinar explores:
- How the development of various disease modifying therapies has significantly improved heart failure outcomes
- An overview of how to practically use these medicines in your patients
- How the funding changes to cilazapril might affect your patients, and alternative options
- A case study: Switching a patient from cilazapril
More information on the changes to cilazapril funding and alternative treatment options is available at:
- Switching blood pressure medications – it’s time to break the cilazapril habit - Dr Chris Ellis
- Cilazapril unplugged – what alternatives? (Bulletin #5) - He Ako Hiringa
- Cilazapril: No new patients from 1 May 2021 - Pharmac
- Prescribing ACE inhibitors: time to reconsider old habits - BPACnz
This video was recorded from a live webinar hosted by He Ako Hiringa on 12 August 2021. The video has been edited for clarity.
Professional college endorsements
This activity has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for 1 CME credit for the General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes. To claim your credits, log in to your RNZCGP dashboard to record this activity in the CME component of your CPD programme.
